Cholangiocarcinoma

BTCRC-GI22-564

Phase 2 Study of Gemcitabine, Cisplatin, Quemliclustat (AB680) and Zimberelimab (AB122) during First-Line Treatment of Advanced Biliary Tract Cancers: Big Ten Cancer Research Consortium BTCRC-GI22-564
Status
Cancer Types
Cholangiocarcinoma
Locations

HCRN-GI19-414

Molecularly Driven, Immune-Based, Maintenance Niraparib and Dostarlimab in Advanced Stage Cholangiocarcinoma  
Status
Closed
Cancer Types
Cholangiocarcinoma
Locations